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Background: Effort tolerance and daily physical activity (DPA) are predictive of quality of life and survival in COPD
patients, but still remain difficult to assess based on their daily life.
The aim of this study was: how to relate pedometry to other classic parameters commonly used in pulmonary
rehabilitation (PR).
Methods: DPA was evaluated through pedometry. 74 patients with COPD, aged 63.55 ± 8.73 (12 stage II, FEV1 = 60.16 ±
7.78%), (29 stage III, FEV1 = 39.07 ± 6.30%), (33 stage IV, FEV1 = 23.1 ± 7.18%). The monitoring was conducted for a period
of 7 days before and 6 months after a pulmonary rehabilitation program (PRP) of 3 weeks. A control group consisting of
21 patients with stable COPD was evaluated initially, but they did not undergo Pulmonary Rehabilitation Program (PRP).
After 6 months the patients were re-evaluated using the same parameters.
Results and discussion: The values are widely dispersed, with a maximum of 17,420 and minimum of 964 steps/24hrs.
The average values acquired were: the lowest in COPD stage IV (2476→3112 steps/24 hrs, p < 0.0001), still with the
highest increase over 6 months of PR + 636steps/24hrs; in COPD stage III the increase of DPA was + 597steps/24hrs
over 6 months (5627→6224, p < 0.0001), COPD stage II registered the lowest increase + 540steps/24hrs (8724→9264,
p < 0.13), probably because the subjects belonging to this stage had the best preserved DPA. The results show
moderate correlation between pedometry and the 6MWT and the SGQ. (r = 0.5-0.7). However it demonstrated the
positive effects of PRP, even after 6 months.
Conclusions: DPA decreases with increasing COPD stage, it is fluctuant with every subject, dependent on clinical
status, weather and daily schedule. Wearing pedometers is very easy and motivational, provided that patients realize
that they are being “watched”.
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The current definition of COPD stipulates that this is a
complex syndrome with significant extrapulmonary mani-
festations [1], where individuals evaluation is both useful
and necessary. The heterogeneity lies in the clinical and
physiological manifestations, the treatment response, the
deterioration of respiratory function and survival [2], which
has led to the initiation of future perspectives of phenotype
of COPD. These are done through distinct clinical, thera-
peutic, and prognostic subcategories. Amongst the signifi-
cant number of extrapulmonary determinations, the loss of
muscular mass induced by the physical inactivity due to* Correspondence: bertnicol2002@yahoo.com
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reproduction in any medium, provided the ordyspnoea is very important, as it determines the decrease of
effort tolerance and life quality.
Daily physical activity (DPA) is considered as the total
of voluntary movements produced by skeletal muscles
above resting levels, carried out during the day [3]. A
study made by Watz et al. [4]. showed that there is a
gradual reduction in the DPA level in COPD patients.
Effort tolerance and DPA are predictive of life quality
and survival in COPD patients, but still remain difficult
to assess based on their daily life [5,6].
Pedometers were initially used in sports. They also
proved their usefulness in the medical field [7,8]. They
register the physical activity (number of steps done) and
estimate the distance in meters and the number of kilo-
calories burned. The values are recorded and allowtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Characteristics of the three groups of patients COPD
COPD II COPD III COPD IV
Patients numbers 12 29 33
Mean Age 63.55 ± 8.73 59.33 ± 4,59 4.59 62.44 ± 10,36 10.36 65,77 ± 7,66 7.66
FEV1 (%) 60.16 ± 7.78 39.07 ± 6.30 23.1 ± 7.18
Origin Urban 66.5% (8 patients) 51.7% (15 patients) 48.48% (16 patients)
52.7% (39 patients)
Rural 33.3% (4 patients) 48.2% (14 patients) 51.5% (17 patients)
47.2% (35 patients)
Body Mass Index Normal 66.6% (8 patients) 44.8% (13 patients) 36.3% (12 patients)
44.5% (33 patients)
Denutrice Wasted 8.33% (1 patient) 34.4% (10 patients) 33.3% (11 patients)
29.7% (22 patients)
Obesity 25% (3 patients) 20.6% (6 patients) 30.3% (10 patients)
25.6% (19 patients)
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ter be worn daily at the belt and maintained during the
whole day. 10,000 steps are recommended per day.
These are the equivalent of 8 km as a standard for an
active and healthy life [9].
Aim
To evaluate the utility of DPA monitoring through pedo-
metry in COPD patients and to relate pedometry with
other classic parameters commonly used in pulmonary re-
habilitation (PR), such as the 6-minute walking test
(6MWT) and Saint-George Quality of Life Questionnaire
(SGQ).
Methods
DPA has been evaluated by pedometry in the case of 74
patients (men) with stable COPD, without significant asso-
ciated pathology and without physical limitations, aged
63.55±8.73 (12 stage II, FEV1 =60.16±7.78%), (29 stage III,
FEV1=39.07±6.30%), (33 stage IV, FEV1 =23.1±7.18%).
These patients were monitored for a period of 7 days. The
test was done before and after 6 months of Pulmonary
Rehabilitation Programs (PRP) of 3 weeks (Tables 1 and 2).
We split our patients in this group after spirometry,
taking into consideration the GOLD guideline 2009. Ini-
tially, each patient had to do spirometry, 6-MWT and
SGQ. Then they had to wear a Canyon pedometer du-
ring the entire day, every day for a week and had to noteTable 2 Results of monitoring the daily physical activity by p
Group N. patients Initially SD
COPD II 12 8724.33 2908.34
COPD III 29 5627.44 2152.95
COPD IV 33 2476.32 2104.12the numbers of steps/24 hours and some comments. The
week log contains patient data (name, age, gender), weight,
height, body mass index, profession, origin (urban or rural),
starting day (season), steps/day and comments on physical
training, spending leisure time and weather. They all had
to undertake a PRP for three weeks. Included in the pro-
gram were the following aims: understanding the disease,
helping patients to give up smoking, cough and sputum
education, adapted diet and physical training with the pur-
pose of stimulating the respiratory and periferic muscles.
The rehab program was carried out in the Department of
Pulmonary Rehabilitation of the Victor Babes Clinical
Hospital of Timisoara on inpatients for 3 weeks (the dur-
ation was approved by the Romanian Health Authorities).
Patients followed sessions of daily training 5 day/week
under the supervision of physiokinotherapists. The physical
effort was individualized for each patient, according to the
severity of the disease, age, BMI, and the pre-existent phy-
sical condition. At the beginning the duration and the in-
tensity of the effort was low (15–20 minutes of the 70% of
the functional capacity). These were increased every 2–3
days. In association there were film sessions, leaflets with
medical education with information concerning the disease,
treatment, and manner of administration, diet, risks (held
by pulmonologists, psychologists, nurses in working day).
After six months, patients were re-evaluated under the
same circumstances with 6-MWT, SGQ, and pedometry
(Tables 3 and 4).edometry
After 6 month SD Change p
9264.16 2405.18 + 540 0.13
6224.42 2105.19 + 597 0.0001
3112.63 2088.46 + 636 0.0001
Table 3 The results obtained to monitoring effort tolerance (6 MWT) and quality of life (SGQ)
COPD stage
(N. patients)
6 Minutes walking test (meters) Quality of life (SGQ -%)
Initially After 6 months Changes Initially After 6 months Changes
COPD II (12) 472.50±63.29 524.58± 62,28 +52 42.47±5.98 38.08±5.20 −4.3
COPD III(29) 415.03±100.0 456.31±109.0 +41 68.17±10.52 62.81±9.549 −5.3
COPD IV(33) 350.20±83.76 383.36±86.75 +33 75,33±12.60 68.58±11.82 −6.7
The control group of 21 patients with COPD that did not follow the PRP, was evaluated under similar conditions. An increase in DPA of + 52.14 steps/day was
noticed without being statistically significant (p = 0.25).
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list with recommendations regarding physical activity
(daily gymnastics, minutes to walk/run, fitness), and diet.
Afterwards, a contact with the patients was made by
telephone every two weeks. The nurses questioned the
patients about their adherence to each chart, and
encouraged them to continue the program. We wanted
to stimulate them to continue their physical training and
treatment as recommended.
A control group consisting of 21 patients with stable
COPD (5 stage II, 7 stage III, and 9 stage IV) were evalu-
ated initially, but they did not undergo PRP. After 6
months, they were re-evaluated using the same para-
meters (Table 5).
The analysis of the results was performed by calcu-
lating the average value (VM) and the standard devi-
ation (SD) to each group and for each parameter
monitored. The Pearson (high statistical value p <0.05)
test was used to establish the level of the statistically
significant modifications that occurred after 6 months,
and with the Beaghehole index 1997 (r<0.20 absent
correlation and r≥0.70 strong correlation) the associ-
ation/correlation strength of these parameters was
decided upon. To evaluate the evolution of each pa-
tient we used the paired t test. To evaluate the norma-
lity of dispersion of the studied groups we used D’
Agostino test.
Results and discussion
Out of the 103 patients initially evaluated, only 74 com-
pleted the re-examination after 6 months. There were 29
patients that dropped out (5 had exacerbations, with 8











COPD II 5 487.6 485.2 43.14
COPD III 7 436.4 431.57 61.87
COPD IV 9 349.5 342.22 69.48
Total/Change 21 - 4.15 + 0.72pedometers daily for a week, 3 had forgotten and mis-
taken data, 1 lost the agenda with the data, and 4
refused the 6 month evaluation). The values registered
by pedometry were widely dispersed with a maximum of
17,420 and minimum of 964 steps/24 hours. The best
preserved DPA had COPD II. The highest increase over
6 months of PR had COPD IV. Only 33 patients had a
normal BMI (44.59%). The others were underweight
(29.7%/22 patients) and overweight (25.6%/19 patients).
The results showed high correlation between 6MWT
and SGQ, whereas between pedometry and the two
above tests the correlation was moderate (r = 0.5 – 0.7).
Patients from an urban background have prevailed be-
cause of greater addressability, higher education level
and better compliance to PRP. As expected, there was a
greater physical activity to patients with occupations that
imply physical work, and to those from rural areas due
to harder labour. The high level of dispersion of the
inter-individual pedometry value is showed by the high
standard deviation for each group.
As demonstrated by other studies, [4,6] DPA decreased
with increasing severity of COPD. The significant im-
provement recorded after PRP is noteworthy, but only in
severe stages (III and IV), probably because these patients
have the most severe restriction and are most compliant
to treatment and medical advice, while in early stages
patients still have largely preserved exercise tolerance.
The patients with extreme values of BMI walked less,
especially those with cachexia, but the differences were
not statistically significant (p-0.15).
A deficiency of the study was that DPA monitoring was
conducted during different seasons (every six months), and
it has been found that weather influences physical activity,6MWT), quality of life (SGQ) and pedometry in control











+ 52.14 (p = 0.25)
Table 5 The results obtained to monitoring the daily





Initially SD After 6
month
SD Change p
COPD II 5 8620.8 1734 8672.2 1607 + 51.2 0.64
COPD III 7 5743.4 875.5 5810.1 852.5 + 66.7 0.34
COPD IV 9 2551.1 653.6 2592.4 749.7 + 41.3 0,61
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especially lower in winter.
More deficiencies were found in the case of the 6MWT,
which has proven to depend on many factors (temperature
and humidity, clothing and footwear worn, food, time of
the test, medication, patients’ psycho-emotional status and
level of motivation/stimulation during the test).
The various elements that influence both 6MWT and
the physical activity evaluated by pedometers explain the
low degree of correlation between the results provided
by these parameters.
In comparison to the 6MWT (often considered tiresome
and stressful), pedometers were much better received by
the patients, being labelled as “personal toys” that follow
them and force them to be more active. The only problem
was that there were patients that forgot to put them on in
the morning. At the end of the study, there were some
patients who were interested in buying such a device.
This study also proved PRP efficiency. This is similar
to other reports [10-12] by emphasizing the significant
improvement of DPA, 6MWT, and QL I in the case of
monitored patients. The effects were long-term, main-
tained to 6 months.Conclusions
DPA decreased with increasing COPD stage. It is fluctuant
from subject to subject, depending on the clinical status,
BMI, weather/season, profession and daily schedule.
Wearing pedometers is very easy and motivational, pro-
vided that patients realize that they are being “watched”.
All these factors determine the PA level. This is the reason
why both its objective evaluation and the establishment of
reference data for each COPD stage are very difficult. But,
at an individual level, these simple instruments proved
their utility, allowing self-monitoring. We suggest that a
10% decrease in average DPA should be taken as an
alarming signal for the outcome of these patients (possible
complications or exacerbations).
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